NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc.

NRBO
NeuroBo Pharmaceuticals, Inc.US flagNASDAQ Capital Market
2.36
USD
- -
- -
20.33MMarket Cap

NeuroBo Pharmaceuticals, Inc. (NRBO) Stock Split History

Learn about NeuroBo Pharmaceuticals, Inc.'s most recent 1-for-8 basis stock split on December 21, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about NeuroBo Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2023-12-21
Split Ratio: 1:8
Price Before Split: $0.44
Price After Split: $0.05

Developer API

Get NRBO split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/NRBO

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 8.00 times fewer shares (a 1:8 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of NeuroBo Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-12-211:8Yes$0.44$0.05
2022-09-131:30Yes$1.00$0.03
2019-12-311:25Yes$0.35$0.01

About NeuroBo Pharmaceuticals, Inc.

Company overview and industry information

NeuroBo Pharmaceuticals, Inc. (NRBO) operates in the Biotechnology industry. The recent 1-for-8 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to NeuroBo Pharmaceuticals, Inc. Summary

Last updated: 7/10/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.